IRB Policies and Guidance - Office of Research Support and Compliance

IRB Policies and Guidance

IRB Policies & Procedures

Current IRB policies and procedures guiding the conduct of human subjects research

IRB Guidance

Guidance from the IRB on special topics

IRB FAQs

Answers to frequently asked questions about human subjects research

2018 Common Rule Update

Information about regulatory changes effective January 21, 2019

Clinical Trials Registration

Information about registering clinical trials and reporting results

IRB Winter Break

The Office of Research Support & Compliance will be closed for winter break on December 23, 2019 and will re-open on January 6, 2020.

Please contact the IRB staff with questions.

If you need to report an unanticipated problem to the IRB or if you have an emergency use request, please call the IRB helpline at 512-232-1543 and leave a detailed voicemail along with your contact information. The IRB staff will be monitoring the voicemail and will return any calls reporting UPs or emergency use requests as appropriate.

Should a situation arise for the emergency use of an unapproved drug, biologic, or device, please consult the IRB’s Policies and Procedures, Section 27.3. Please note, prior notification to the IRB is not required; however, a 5-day follow-up report after use must be submitted for review. Additional information regarding emergency use can be found here https://utexas.box.com/v/EmergentUseRequest.